Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct;9(5):1997-1999.
doi: 10.1002/epi4.12948. Epub 2024 Aug 22.

Successful use of cannabidiol in nonconvulsive status epilepticus in Angelman syndrome

Affiliations
Case Reports

Successful use of cannabidiol in nonconvulsive status epilepticus in Angelman syndrome

Nicola Pietrafusa et al. Epilepsia Open. 2024 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

PN has received speaker fees or fundings or has participated in advisory boards for Angelini and UCB. DPL, AM, CT report no conflict of interest. VF has received speaker fees or fundings or has participated in advisory boards for Zogenix, Neuraxpharm, Angelini, Eisai, and Neuraxpharm. SN has served on scientific advisory boards for GW Pharma, BioMarin, Arvelle, Marinus, and Takeda; has received speaker honoraria from Eisai, Biomarin, Livanova, Sanofi; has served as an investigator for Zogenix, Marinus, Biomarin, UCB, Roche.

Figures

FIGURE 1
FIGURE 1
EEG during the drowsiness and frequent seizures. This patient was recorded few days after the symptoms began. Continuous high amplitude, diffuse, irregular spike–wave complexes with higher amplitude over bilateral frontal regions, in sequences with a rhythmic‐recruiting pattern (A). Oromucosal midazolam was administered without significant changes (B). After 1 day EEG still showed continuous spike and waves discharges, EMG channels show multiple asynchronous and asymmetric myoclonic jerks over bilateral deltoids, and neck muscles. The patient was also presenting head drops typically seen in NCSE (minor motor status). Both valproate (C) and levetiracetam (D) were ineffective. He started Epydiolex CBD and after 2 days (E) and 7 days (F) there was a marked reduction of EEG epileptiform abnormalities and a resolution of NCSE. After 15 days (G) still some repetitive spikes were evident over asynchronous bilateral temporal and parietal regions. After 29 days (H), there was an improvement of background activity, further reduction in epileptiform abnormalities and the patient was persistently free from seizures.

References

    1. Duis J, Nespeca M, Summers J, Bird L, Bindels‐de Heus KGCB, Valstar MJ, et al. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med. 2022;10:e1843. - PMC - PubMed
    1. Bindels‐de Heus K, Mous SE, Ten Hooven‐Radstaake M, van Iperen‐Kolk BM, Navis C, Rietman AB, et al. An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. Am J Med Genet A. 2020;182:53–63. - PMC - PubMed
    1. European Medicines Agency . Epidyolex [Internet]. Human medicine European public assessment report (EPAR) last updated on 04/07/2023 [cited 2023 Oct 10]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolex.
    1. Kühne F, Becker LL, Bast T, Bertsche A, Borggraefe I, Bobelmann CM, et al. Real‐world data on cannabidiol treatment of various epilepsy subtypes: a retrospective, multicenter study. Epilepsia Open. 2023;8:360–370. - PMC - PubMed
    1. Gu B, Zhu M, Glass MR, Rougié M, Nikolova VD, Moy SS, et al. Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice. J Clin Invest. 2019;129:5462–5467. - PMC - PubMed

LinkOut - more resources